雲鼎科技(000409.SZ):公司人工智能多模態技術正處於研發階段
格隆匯1月23日丨雲鼎科技(000409.SZ)在投資者互動平台表示,目前公司的人工智能主要研發應用於能源行業智能化場景的建設,解決行業應用問題,公司人工智能多模態技術正處於研發階段,將優先在山東能源集團內部進行試點應用,運行成熟穩定後逐步向山東能源集團外部推廣。公司當前已與多個多模態廠家進行了技術交流,未來我們將積極與其他業界公司和產研單位開展合作,集成多模態生態體系,拉通供應鏈上下游企業,打造人工智能生態圈。公司開發的AI場景全部基於國產AI芯片,在算力上與其他業界公司進行合作,目前沒有投資通用算力的意向。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.